1 study found for:    cholangiocarcinoma AND trisomy 7 | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Erlotinib for Chemoprevention in Trisomy 7 Positive Primary Sclerosing Cholangitis (PSC)
Conditions: Primary Sclerosing Cholangitis;   Trisomy 7;   Cholangiocarcinoma;   Chemoprevention
Intervention: Drug: Erlotinib (Tarceva)

Indicates status has not been verified in more than two years